Recettore Trk
Gli inibitori dei recettori Trk prendono di mira le chinasi recettoriali della tropomiosina (Trk), una famiglia di tirosina chinasi recettoriali che svolgono un ruolo significativo nello sviluppo e nella funzione del sistema nervoso. I recettori Trk sono coinvolti nella segnalazione delle neurotrofine, essenziale per la sopravvivenza, la differenziazione e la crescita dei neuroni. La disregolazione della segnalazione Trk è associata a disturbi neurologici e ad alcuni tipi di cancro. Presso CymitQuimica, offriamo inibitori dei recettori Trk per supportare la tua ricerca in neurobiologia, oncologia e malattie neurodegenerative.
Trovati 59 prodotti di "Recettore Trk"
Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
GNF-5837
CAS:<p>GNF-5837 is a specific, and orally bioavailable pan-TRK inhibitor for TrkA/TrkB (IC50: 8/12 nM).</p>Formula:C28H21F4N5O2Purezza:97.26% - 98.08%Colore e forma:SolidPeso molecolare:535.49DS-1205
CAS:<p>DS-1205: AXL kinase inhibitor (IC50=1.3 nM), also targets MER, MET, TRKA (IC50s: 63, 104, 407 nM), hinders cell migration and tumor growth.</p>Formula:C41H42FN5O7Purezza:99.75%Colore e forma:SolidPeso molecolare:735.8GW 441756
CAS:<p>GW 441756 is a specific Tropomyosin-related kinase A (TrkA) inhibitor with an IC50 value of 2 nM.</p>Formula:C17H13N3OPurezza:97.73% - 99.8%Colore e forma:SolidPeso molecolare:275.3Tyrphostin AG 879
CAS:<p>Tyrphostin AG 879 (AG 879) effectively inhibits HER2/ErbB2 (IC50: 1 μM), 100- and 500-fold higher selective to ErbB2 than EGFR and PDGFR.</p>Formula:C18H24N2OSPurezza:99.05%Colore e forma:SolidPeso molecolare:316.46Sitravatinib
CAS:<p>Sitravatinib (MGCD516) (MGCD516) is an inhibitor targeting multiple RTKs involved in driving sarcoma cell growth, including c-Met, c-Kit, PDGFRα/β, PDGFR, and</p>Formula:C33H29F2N5O4SPurezza:98.9% - 99.85%Colore e forma:SolidPeso molecolare:629.68LM22B-10
CAS:<p>LM22B-10 is an activator of TrkB/TrkC neurotrophin receptor and can induce TrkB, TrkC, ERK and AKT activation in vitro and in vivo.</p>Formula:C27H33ClN2O4Purezza:98.18%Colore e forma:SolidPeso molecolare:485.01Larotrectinib
CAS:<p>Larotrectinib (LOXO-101) is an orally administered inhibitor of the TRK kinase and is highly selective only for the TRK family of receptors(IC50s = 2-20 nM).</p>Formula:C21H22F2N6O2Purezza:99.15% - >99.99%Colore e forma:SolidPeso molecolare:428.44CH7057288
CAS:<p>CH7057288 is an effective and selective TRK inhibitor with an IC50 value of 1.1 nM, 7.8 nM and 5.1 nM for TRKA, TRKB and TRKC, respectively.</p>Formula:C32H31N3O5SPurezza:99.92%Colore e forma:SolidPeso molecolare:569.67Larotrectinib sulfate
CAS:<p>Larotrectinib sulfate (LOXO-101 sulfate) is an oral active and specific ATP-competitive inhibitor of tropomyosin receptor kinases (TRK).</p>Formula:C21H22F2N6O2·H2O4SPurezza:98.62% - 99.76%Colore e forma:SolidPeso molecolare:526.51Repotrectinib
CAS:<p>Repotrectinib (TPX-0005) is a potent ALK/ROS1/TRK inhibitor, with IC50 of 1.01/5.3/1.08/1.26 nM for WT ALK, SRC, ALK L1196M and ALK G1202R, respectively.</p>Formula:C18H18FN5O2Purezza:99.92% - >99.99%Colore e forma:SolidPeso molecolare:355.377,8-Dihydroxyflavone
CAS:<p>7,8-Dihydroxyflavone (7,8-DHF) is a naturally-occurring flavone and exist in Tridax procumbens, Godmania aesculifolia, and primula tree leaves.</p>Formula:C15H10O4Purezza:98.48% - 99.81%Colore e forma:SolidPeso molecolare:254.24Frunevetmab
CAS:<p>Frunevetmab (NV-02) is a feline-adapted monoclonal antibody targeting NGF (nerve growth factor), with a Kd value of 20 pM. Feline osteoarthritis (OA).</p>Purezza:95% - 95%Colore e forma:LiquidFasinumab
CAS:<p>Fasinumab (anti-NGF mAb) is in Phase III trials for acute sciatica & knee OA. It significantly improves pain & function vs. placebo.</p>Purezza:95%Colore e forma:LiquidFulranumab
CAS:<p>Fulranumab (AMG-403) is a humanised monoclonal antibody targeting NGF, analgesic effects, and can be used for the study of chronic pain.</p>Purezza:95%Colore e forma:LiquidTanezumab
CAS:<p>Tanezumab (RN-624) is a humanised monoclonal antibody targeting NGF，pain conditions, including osteoarthritis, knee arthritis, and neuropathic pain.</p>Purezza:95%Colore e forma:LiquidBMS-754807
CAS:<p>BMS-754807 is an oral IGF-1R/InsR inhibitor with potential anti-cancer properties.</p>Formula:C23H24FN9OPurezza:99.69% - 99.94%Colore e forma:SolidPeso molecolare:461.49Protein kinase inhibitor 5
CAS:<p>Protein kinase inhibitor 5 is a potent inhibitor of TRK-A, demonstrating an IC50 of 1.8 nM, and effectively suppresses cell viability [1].</p>Formula:C29H31F2N7OPurezza:98%Colore e forma:SolidPeso molecolare:531.6Tavilermide
CAS:<p>Tavilermide (MIM-D3) is a selective TrkA agonist, a cyclic mimetic, which can be used to study dry keratoconjunctivitis and dry eye syndrome.</p>Formula:C24H32N6O11Purezza:98.98%Colore e forma:SolidPeso molecolare:580.54TrkA-IN-1
CAS:<p>TrkA-IN-1 is a potent and selective inhibitor of Tropomyosin-related kinase A (TrkA) (IC50: 99 nM in a cell-based assay) with analgesic activity.</p>Formula:C25H20N4OPurezza:98%Colore e forma:SolidPeso molecolare:392.45Paltimatrectinib
CAS:<p>Paltimatrectinib (PBI-200) is a tyrosine kinase inhibitor with anticancer activity, and is used in the study of bladder, breast, and colorectal cancers.</p>Formula:C20H15F5N6Purezza:99.96%Colore e forma:SolidPeso molecolare:434.37
